Synthesis and Antioxidant Activity of Prenylated Resveratrol

Abstract

Resveratrol derivatives have been reported to have important bioactivities. Synthesis of monomeric resveratrol derivatives has been a challenging topic in both organic and medicinal chemistry. A Synthesis of prenylated resveratrol was developed through prenylation between resveratrol (3,5,4'-trihydroxystilbene) and prenyl bromide (3,3-dimethyl allyl bromide) using heterogeneous superbase catalyst γ-Al2O3/NaOH/Na. The aim of this research is to obtain prenylated resveratrol compound that has important bioactivity and to identify a type of prenylation, O-or C-prenylation. Characterization of the product was carried out using liquid chromatography-mass spectrometry (LC-MS) and nuclear magnetic resonance ( 1 H-NMR). The antioxidant activity of the samples was determined using DPPH radical scavenging assay. The results of LC-MS analysis of the product showed the molecular ion peak at m/z 365.38 [M+H] + that indicated the presence of prenylated resveratrol with two prenyl (C5H9-) substituent. The 1 H-NMR spectrum of the product indicated that the addition of two prenyl substituent occurs at the hydroxyl group on the structure of resveratrol (O-prenylation). Prenylation caused decreasing free radical scavenging activity of the product (IC50 = 102,75 ppm) compared to resveratrol (IC50 = 63,52 ppm) and it means that the addition of prenyl substituents occurs through O-prenylation.

Synthesis and Antioxidant Activity Study of New Mannich Bases Derived From Vanillic Acid

“…The antioxidant activities of synthesized compounds (2a-e) and vanillic acid evaluated spectrophotometrically following the procedure of free-radical DPPH scavenger and Ferric ion Reducing Activity Potential (FRAP) as reported previously, with slight modification. 5,[17][18] Quercetin was used as a standard.…”

Synthesis and Antibacterial Activity of Novel Vanillic Acid Hybrid Derivatives

“…Polyphenols are commonly divided into flavonoids and the hydroxyl cinnamic acids [3][4][5] . Vanillic acid is a naturally occurring active compound having antimicrobial, anti-inflammatory and antioxidant / anticancer properties, we thought of synthesizing compounds with a novel ether, ester and hybrid derivatives of vanillic acid wherein vanillic acid would be etherified, esterified and hybridized with various other compounds and to check whether these compounds possess above biological activities [6][7][8][9][10][11][12][13][14][15][16][17][18] . The objective of this study is to condense two molecules of the same disease domain to produce more potent candidate in the same disease domain or to condense two molecules of different disease domain to produce a mixed variety of those disease domain or to have drug candidate with entirely different biological activity.…”